PPGFST PROGRAMA DE PÓS-GRADUAÇÃO EM FISIOTERAPIA CENTRO DE CIÊNCIAS DA SAÚDE Teléfono/Ramal: (84) 3342-2002 https://posgraduacao.ufrn.br/ppgfst

Banca de QUALIFICAÇÃO: RAFAELA JÉSSICA SILVEIRA DE SOUZA

Uma banca de QUALIFICAÇÃO de MESTRADO foi cadastrada pelo programa.
STUDENT : RAFAELA JÉSSICA SILVEIRA DE SOUZA
DATE: 14/06/2024
TIME: 14:00
LOCAL: presencial
TITLE:

Impact of the association of stretching and photobiomodulation on chronic pelvic pain and sexual function in adult women: a clinical trial protocol


KEY WORDS:

Pelvic Floor Disorders. Stretching Exercises. Physical Therapy Modalities. Low-Level Light Therapy.


PAGES: 35
BIG AREA: Ciências da Saúde
AREA: Fisioterapia e Terapia Ocupacional
SUMMARY:

Introduction: Chronic pelvic pain (CPP) is a multifactorial pathology affecting one in six adult women, characterized by persistent pelvic pain associated with the involvement of the genitourinary, gastrointestinal, and musculoskeletal systems. It is also linked to sexual dysfunction and significant mood changes, directly impacting the reduction of quality of life. Stretching is a therapeutic alternative for restoring the functional integrity of the pelvic floor muscles. Concurrently, other strategies have emerged as effective alternatives to support established protocols, among which photobiomodulation (PBM) stands out. PBM involves the emission of low-intensity light to modulate the inflammatory process and tissue repair, providing analgesic effects on skeletal muscles and alleviating symptoms related to female sexual dysfunction (FSD) and CPP. Consequently, this study aims to analyze the association of stretching with PBM in the treatment of CPP and FSD. Methods: This is a prospective, randomized controlled trial to be conducted by a specialized team from the Department of Physical Therapy at the Federal University of Rio Grande do Norte (UFRN), located in Natal, Rio Grande do Norte, Brazil. Female individuals aged 18 to 50 years, with active sexual life, diagnosed with CPP, and reporting sexual dysfunction complaints, will be recruited. Eligible participants will be coded and randomized in a 1:1 allocation ratio into two blocks: control group with stretching + intravaginal laser therapy with the device turned off, and experimental group (EG) with stretching + intravaginal laser therapy with the device on. Reassessments will occur after the 5th session, 10th session, and three and six months after the last session. Pain assessment will be measured using the Numerical Rating Scale, while sexual function assessment will be conducted using the Female Sexual Function Index (FSFI) questionnaire. The photobiomodulation device used will be the Fluence Maxx HTM®. Expected Results and Impacts: A positive outcome is anticipated in the reduction of CPP symptoms and an improvement in the patients' sexual quality of life, enabling the development of a standardized, safe, and effective protocol to be applied in both laboratory and clinical practice.

 


COMMITTEE MEMBERS:
Presidente - 2212151 - ELIZABEL DE SOUZA RAMALHO VIANA
Interna - 4933786 - VANESSA PATRICIA SOARES DE SOUSA
Externo à Instituição - RODRIGO MARCEL VALENTIM DA SILVA - ESTACIO
Notícia cadastrada em: 29/05/2024 08:58
SIGAA | Superintendência de Tecnologia da Informação - (84) 3342 2210 | Copyright © 2006-2024 - UFRN - sigaa10-producao.info.ufrn.br.sigaa10-producao